Finzati - Logo
PRE logo

Prenetics Global Limited

PREMedical - Diagnostics & Research
$25.44
-0.19 (-0.74%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$318.93M
Growth
31.9%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 18.0%Manageable debt level · 0.01Healthy liquidity · 3.01Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$25.44
Change-0.74%
Market Cap$318.93M
52W Range7.17 - 23.63
Beta0.25
Gross Margin52.81%
Oper. Margin-41.27%
Profit Margin-40.82%
Debt/Eq0.01
Current Ratio3.01
Quick Ratio2.76
Revenue 5Y31.91%

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score
Positive revenue growth · 18.0%Manageable debt level · 0.01Healthy liquidity · 3.01Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-20
Low
$35.00
Mean
$35.00
Median
$35.00
High
$35.00

Company Overview

IPO: 7/16/2021
Industry: Medical - Diagnostics & Research
P/B i: 1.27
Debt / Equity i: 0.01
Operating Margin: -41.27%
Net Margin: -40.82%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 3.01
Quick Ratio: 2.76
Status: Good

Insider Transactions

Recent executive and insider activity

Tat Thuan Yen
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/12/2026
Type
OTHER
Leogrande Hudson Blake
Transaction: 08/04/2026
BUY
Change
+2,001
Price
Not reported
Filing
08/05/2026
Type
BUY
Leogrande Hudson Blake
Transaction: 08/04/2026
SELL
Change
-2,001
Price
Not reported
Filing
08/05/2026
Type
SELL